Kannivelu Jagannath

A Randomized, Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Tolerability of Risorine with Conventional Rifampicin in the Treatment of Newly Diagnosed Pulmonary Tuberculosis Patients.

Naresh M. Patel, Kannivelu Jagannath, Agam Vora, Mukesh Patel et autres

BACKGROUND: The overall goals for treatment of Tuberculosis (TB) are to cure individual patient and to minimize the transmission of Mycobacterium tuberculosis. At the time of study conduction, the standard treatment for newly diagnosed tuberculosis patients consisted of an intensive phase for …

in (code pays fourni par la source)

Randomized Clinical Trial of Thrice-Weekly 4-Month Moxifloxacin or Gatifloxacin Containing Regimens in the Treatment of New Sputum Positive Pulmonary Tuberculosis Patients

Mohideen Shaheed Jawahar, Vaithilingam V. Banurekha, Chinnampedu N. Paramasivan, Rajeswari Ramachandran et autres

BACKGROUND: Shortening tuberculosis (TB) treatment duration is a research priority. This paper presents data from a prematurely terminated randomized clinical trial, of 4-month moxifloxacin or gatifloxacin regimens, in South India. METHODS: Newly diagnosed, sputum-positive HIV-negative pulmonary TB patients were randomly allocated to …

in (code pays fourni par la source)

A rare disappearing right atrial mass

V. R. K. Rao, Kannivelu Jagannath, P. K. Sunil, N. Madhusudana

Cardiac tuberculosis is rare and usually involves the pericardium. Myocardial tuberculoma is a very rare occurrence and only a few cases have been reported. We describe a rare case of cardiac tuberculoma involving the whole of the lateral right atrial wall, extending …

in (code pays fourni par la source)

Randomized Placebo Controlled Study of Ciclesonide in Preschool Children with Recurrent Wheeze and a Positive Asthma Predictive Index or Atopy

Paul L.P. Brand, Kannivelu Jagannath, María Luz García‐García, Jan Hendrik Vermeulen et autres

nl, es, Afrique du Sud (code pays fourni par la source)

Comparison of the efficacy of ciclesonide 160 μg QDand budesonide 200 μg BID in adults with persistent asthma: A phase III, randomized, double-dummy, open-label study

Pramod V. Niphadkar, Kannivelu Jagannath, Jyotsna Madanmohan Joshi, Nilkanth Tukaram Awad et autres

in, nl (code pays fourni par la source)

Ciclesonid einmal täglich ist so wirksam wie Budesonid zweimal täglich hinsichtlich Verbesserung der Lungenfunktion und der Asthma-Kontrolle

Stefan Hellbardt, D.A. Gadgil, Pramod V. Niphadkar, Kannivelu Jagannath et autres

Einführung: Für Ciclesonid (CIC), ein neues, „on site“-aktiviertes inhalatives Kortikosteroid, wurde bereits in zahlreichen klinischen Untersuchungen gezeigt, dass es die Lungenfunktion und Symptom-Kontrolle bei Asthma-Patienten verbessert. In dieser Studie wurde die Wirksamkeit der einmal täglichen Gabe von Ciclesonid mit einer zweimal täglichen …

nl, in (code pays fourni par la source)

Once-daily ciclesonide is as effective as twice-daily budesonide in maintaining lung function and asthma control in patients with asthma

D.A. Gadgil, Pramod V. Niphadkar, Kannivelu Jagannath, Jyotsna Madanmohan Joshi et autres

in, nl (code pays fourni par la source)

Brief communication: rapid culture of tubercle bacilli.

R. Vasanthakumari, Kannivelu Jagannath

One of the biggest obstacles to the correct diagnosis and efficient treatment of tuberculosis is the absence of a rapid technique for culturing tubercle bacilli and for testing their susceptibility to antituberculosis drugs. Current procedures typically take 6-10 weeks to perform. This …

in (code pays fourni par la source)

Multidrug Resistant Tuberculosis - A Tamilnadu Study

R. Vasanthakumari, Kannivelu Jagannath

A study was conducted at the Institute of Thoracic Medicine, Chennai to find out the prevalence of multidrug resistant tuberculosis (MDRTB) among patients undergoing anti tuberculosis treatment for varying periods of time at four tuberculosis centres in Tamil Nadu. All patients were …

Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis.

Chandra Immanuel, R Swamy, M Kannapiran, S. P. Vijayalakshmi et autres

SETTING: Cell-mediated immunity (CMI) involves macrophage activation and T cell proliferation. These two parameters are compared in this study. OBJECTIVE: To ascertain the role of neopterin as a biochemical marker for CMI in patients with pulmonary tuberculosis. DESIGN: We measured neopterin levels …

in (code pays fourni par la source)

Detection of HIV infection in pulmonary tuberculosis patients.

Samuel Nm, C Alamelu, Kannivelu Jagannath, Rajan Bp

Well documented 112 pulmonary tuberculosis patients were studied for the prevalence of human immunodeficiency virus (HIV) seropositivity by using two antibody screening tests along with western blot test. Nineteen of the pulmonary tuberculosis patients were HIV seropositive, 12 were acid-fast bacillus smear …

in (code pays fourni par la source)

A cold staining method for acid-fast bacilli

R. Vasanthakumari, Kannivelu Jagannath, S. Rajasekaran